synonymSinopharm Group(Central enterprises managed by the State owned Assets Supervision and Administration Commission of the State Council) generally refer to China National Pharmaceutical Group Co., Ltd
China Pharmaceutical Group Co., Ltd. is a central enterprise directly managed by the State owned Assets Supervision and Administration Commission of the State Council, focusing on life and health. It has a whole industrial chain of scientific and technological research and development, industrial manufacturing, logistics distribution, retail chain, medical health, engineering technology, professional exhibition, international operation, and financial investment.It has more than 1700 subsidiaries and Sinopharm HoldingsSinopharm, consistent with Chinese medicineTiantan Biology9 listed companies, including Sinopharm Modern, Chinese Traditional Medicine, Sinopharm Taiji, Top Nine Biology, and Weiguang Biology, with a total number of 230000 employees.[34]
On September 1, 2019, ranked 22nd in the 2019 Top 500 Chinese Service Enterprises[1]；In April 2020, it was selected into the "Science and Technology Reform Demonstration Enterprise" list of the State owned Assets Supervision and Administration Commission of the State Council;Year 2020Assessment of business performance of persons in charge of central enterprisesClass A enterprise[18]；2023 FortuneWorld Top 500The 113th bit[33]。
Distribution, retail and research and development of health related products
Company type
company with limited liability[14](State holding)
Annual turnover
US $94.075 billion[2][27][31]
Number of employees
About 230000 people[34]
Abbreviation
Sinopharm, Sinopharm, SINOPHARM
Honors won
World Top 500 (113th in 2023)[33]
Official website
http://www.sinopharm.com/
Business Information
intellectual property right
Unified social credit code:
91110000100005888C
Organization code:
one hundred million five thousand eight hundred and eighty-eight
Registration No.:
one hundred trillion and five thousand eight hundred and eighty-two
Business status:
Opening
Company type:
Limited liability company (state-owned holding company)
Date of establishment:
March 26, 1987
Legal representative:
Liu Jingzhen
Business Term:
November 22, 2017
Registered capital:
25506579351 yuan
Date of audit/annual inspection:
November 18, 2019
Registration authority:
Beijing Municipal Market Supervision Administration
Business address:
20 Zhichun Rd, Haidian District, Beijing
Business scope:
Wholesale of Chinese patent medicines, Chinese herbal pieces, Chinese medicinal materials, chemical APIs, chemical preparations, antibiotics, biochemical drugs, and biopharmaceuticals (the validity of the drug business license expires on May 12, 2020);Entrusted management and asset restructuring of pharmaceutical enterprises;Pharmaceutical industry investment and consulting services;Holding exhibitions and sales of medical devices;Provide consulting services related to main business;Import and export of goods;Technology import and export;Acting as import and export agent.(The enterprise shall independently choose the business items and carry out business activities according to the law; the business items that need to be approved according to the law shall be carried out according to the approved contents after being approved by the relevant departments; the enterprise shall not engage in the business activities of the items prohibited and restricted by the city's industrial policies.)
China Pharmaceutical Group Co., Ltd. is committed to "caring for life and health"Corporate philosophy, responsible for the countryRescue and disaster reliefDrugs, biotechnology products, Chinese medicinal materials, medical devicesCentral reserve, allocation and supply tasks in 1976 Tangshan earthquake, 1998combat a flood and go to the rescue hurriedly, 2003Fight against SARSIn the battle;Wenchuan earthquake relief in 2008, prevention and control in 2009Influenza A (H1N1)Epidemic situation, Yushuhe in 2010ZhouquThe scene of earthquake relief;In 2008Olympic Games、2009 National Day ParadeAnd Shanghai in 2010the World ExpoAnd other major eventsMaterial reserveAnd emergency supply, and the 2010 nationalMeasles vaccineBooster immunityDuring the activity, we can see the tense work of Sinopharm people, which has played an important role in ensuring people's life and health and social stability.At the same time, the vaccines developed and produced by the Group are exported to IndiaThailand, KoreaNepal、Sri LankaAnd other countries have made positive contributions to the health of local people.
China Pharmaceutical Group Co., Ltd. is the chairman unit of 9 pharmaceutical industry organizations and China PharmaceuticalHealthThe largest exhibition and conferenceorganizer。The Group has long undertaken the task of national medical material reserve and emergency supply, playing an important role in ensuring social public health safety and people's life and health, and promoting the development of the industry.
China Pharmaceutical Group Co., Ltd. takes "caring for life and health" as its corporate philosophy, and aims to create an industry leading pharmaceutical group with international competitiveness.It has production enterprises, scientific research and design institutes, medicinal materials planting bases andLarge and medium-sized citiesBasically covering the whole countrymarketing network 。In September 2009, with the approval of the State Council, China National Pharmaceutical Corporation andChina Biotechnology Group CorporationimplementJoint reorganizationSo far, SASAC has fulfilledResponsibilities of investorsFrom 136 to 135.In August 2016, China Pharmaceutical Group Corporation ranked 45th among the "2016 Top 500 Chinese Enterprises".[3]
Company History
Announce
edit
Since its establishment, the enterprises affiliated to China National Pharmaceutical Group Co., Ltd. have been responsible for the national rescue and relief drugs, Chinese medicinal materials, medical equipmentCentral reserve, allocation and supply tasks. At a critical time, China Pharmaceutical Group Corporation has played an important role in ensuring people's life and health and social stability.Fight in 2003SarsIn China, China Pharmaceutical Group Corporation acts as the national SARS prevention headquarterslogistic serviceThe member units mobilized more than 100 enterprises in the group system to allocate a total amount of 130 million yuan of SARS prevention and treatment medical supplies to 22 provinces, autonomous regions and municipalities directly under the Central Government;170 million yuan of medical supplies for SARS prevention and treatment were supplied to Beijing and other key areas, and the central assistance was successfully completedHong Kong SARThe medical supplies for SARS prevention and treatment worth more than 30 million yuan in Macao SARSource OrganizationAnd supply work have been awarded by the State owned Assets Supervision and Administration Commission and the National Development and Reform Commission.During the earthquake relief in 2008, China Pharmaceutical GroupRapid responseWe went all out to complete the allocation of medical supplies for earthquake relief amounting to 300 million yuan, which played an important role at a critical moment.
On December 15, 2012, China Pharmaceutical Group Investment HoldingModern sunshineThe signing ceremony of physical examination was held in Beijing. China Pharmaceutical Group and Beijing Modern Sunshine Health Technology Co., Ltd. jointly established Sinopharm Sunshine Health Technology Co., Ltd,Registered capital89.8 million.
In January 2020, China Pharmaceutical Group Co., Ltd. specially set up 1 billion yuanSpecial fundsFor newcoronavirus infectionspneumoniaEpidemic situation.[4]In April 2020, it was selected into the "Science and Technology Reform Demonstration Enterprise" list of the State owned Assets Supervision and Administration Commission of the State Council.
On October 20, 2020, Sinopharm GroupInactivated neocoronal vaccineAt the stage of full sprint, the research and development of biological vaccine is still a long journeyLast kilometer, onPhase III clinical trialAfter obtaining safety and protection data, the vaccine can be marketed after being reviewed and approved.[5]
On August 17, 2021, Sinopharm andState Machinery GroupSigningStrategic Cooperation Agreement。The two sides will carry out all-round and in-depth cooperation in various fields to establish a more stable and extensiveStrategic partnershipAnd jointly promote the implementation of national strategies.The two sides will establish and gradually improve a long-term contact mechanism, carry out regular exchanges, and promote the implementation of cooperation matters.[19]
On March 28, 2022,China RailwayChen Yun, the chairman of the board, held talks with Liu Jingzhen, the chairman of Sinopharm Group, and conducted in-depth exchanges on relevant cooperation issues.After the meeting, China Railway and Sinopharm officially signed a strategic cooperation framework agreement.[23]
On April 26, 2022, the inactivated vaccine of Sinopharm Sinopharm Biologica Omikron mutant COVID-19 was approved by the State Food and Drug Administration.[24]
1. Entrepreneurship is not just for start-ups.In fact, enterprises are always in the process of entrepreneurship.
2. Change is a part of life.But few people expect or consciously accept the changes that are taking place in their lives.Let's adjust in time, adapt ourselves to changes, and help ourselves succeed in the changing times.
3. Passion, yesWinnersLogo of.Passion is not flamboyant, but something in the inner world.The sign of an excellent enterprise is that it can ignite employees' work passion.
4. Being a man should be based on honesty.In this way, we can establish a relationship with customers, supplierscompetitorGood relationship with banks and governments.
5. Persistence and perseverance are the essential characteristics of successful entrepreneurs. This kind of perseverance comes from entrepreneurs'Personality traitAnd belief in entrepreneurship.
6. Digital is the ability that successful entrepreneurs always pay attention to and must master.The most valuable information is the number related to profit.Provide funds to everyone who doesn't understandFinancial statement analysis"Entrepreneurs" who do not understand various business figures willSteering wheelGive it to a blind man.
Qualification and honor
Announce
edit
2003 Humanity Care Award
2003 Selfless Contribution Award
Advanced grass-roots party organizations in 2003
Ranked among the top 500 enterprise groups in China in 2004
Ranked among the top 500 enterprise groups in China in 2005
"Listed" among the top 500 enterprise groups in China in 2006
On July 12, 2017, China Pharmaceutical Group Corporation was awarded the title of "2016 Operation" by SASACPerformance assessmentGrade A.[6]
On July 19, 2018,2018 Fortune Global 500It was announced that China Pharmaceutical Group ranked 194.[7]
On September 1, 2019,2019 Top 500 Chinese EnterprisesIt was announced that China Pharmaceutical Group ranked 43rd;[8]In 2019, China's top 500 service enterprisesIssued by JinanChina Pharmaceutical Group Co., Ltd. ranked 22nd.[1]
In July 2023, it ranked No. 1 in the Fortune China 500 list with an operating income of $94.075 billion34 bits.[31]
In August 2023, with a revenue of 94075.2 million US dollars, he was listed in the Fortune Global 500 list in 2023, ranking 113.[32]
Development objectives
Announce
edit
Sinopharm established "trade, science and industry" as a long-termdevelopment strategy The medium and long-term development goals are divided into three stages:
The second stage goal is to achieve the sales revenue of the Group's main business of 100 billion yuan by 2012;
The third stage is to strive to enter the world's top 500 by 2015.
SinopharmStrategic positioningYes: market-oriented, to be an industrial integrator integrating Chinese medicine trade, science and industry.
R&D work
Announce
edit
Sinopharm GroupChinese BiologyIn 3technology roadmap upperAll haveLayout the research and development work for the variant strains of Omikjon.Among them, Beijing Institute of Biology and Wuhan Institute of Biology will be responsible forInactivated vaccineConduct cross neutralization experiment;Sinopharm China Institute of Biology has launched Omikron strainGene mapDesign, under constructioncell line；Sinopharm Sinopharm also launched the research and development of Omikron strain vaccine.Sinopharm Sinopharm Biotech will do a good job of storing all mutant vaccines at the first time.[21]
On May 5, 2023, Sinopharm and Fudan University signed a strategic cooperation framework agreement in Shanghai.The two sides will jointly build a national innovation platform, cooperate in the development of new products and technologies, and strengthen the training and cooperation of scientific and technological talents.[30]
corporate culture
Announce
edit
Corporate image
Sinopharm Group logo
Structure:The LOGO uses the upper part of the Chinese character "goodness" to simplify the image of forming surging water ripples, implying Sinopharm's mind and realm like water, which is favored by all things, modest and inclusive;LOGO+Chinese and English combination, the overall structure is "good", meaning "the highest good is like water".
Color:Green, blueLake blueMatching, the green space, blue sky and sea are organically integrated, implying that the three systems of commerce, scientific research and industry of Sinopharm Group work together for common prosperity.
Modeling and implication:
The sign trend of spiral upward growth is like a gene in lifeDNA, highlighting industry attributes and future development prospects;
The overall design presents a heart shape, which symbolizes a heart of life that gathers care, responsibility, innovation and sharing, and carries the boundless love.
LOGO design fully reflects the "care, responsibility, innovation and sharing" of Sinopharm brandCore values。
The best: the best, the most perfect;
Water: It is a kind of humility to avoid heights and move downward; it is a kind of pursuit to rush to the sea; it is a kind of ability to combine hardness and softness; it is a kind of magnanimity to accept hundreds of rivers; it is a kind of perseverance to drop water and pierce stones; and it is a kind of dedication to wash sewage.
Corporate Vision
China Pharmaceutical Group has always adhered to the corporate philosophy of "caring for life and health" and actively implementedcentral enterprisespolitical responsibility, social responsibility andEconomic responsibilityAnd play an important role in ensuring people's health and social stability.
Deputy Secretary of the Commission for Discipline Inspection: Wang Songlin
Members of the Commission for Discipline Inspection:Yang JunZhu JingjinYang Wenming[13]
Social public welfare
Announce
edit
On July 22, 2021, the member enterprises of Sinopharm Group have donated the first batch of 22 million yuan in cash through Henan Charity FederationXinxiang Red Cross SocietyDeliver to the disaster area.Sinopharm Groupsurplus value8 million yuancontributionAnd supplies will also arriveHenan ProvinceFlood fighting and disaster relief.[17]
